ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO)
CUSIP: 00166B105
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 132,496,020
- Total 13F shares
- 34,283,564
- Share change
- -1,402,460
- Total reported value
- $257,462,824
- Put/Call ratio
- 13%
- Price per share
- $7.51
- Number of holders
- 74
- Value change
- -$6,376,897
- Number of buys
- 37
- Number of sells
- 40
Quarterly Holders Quick Answers
What is CUSIP 00166B105?
CUSIP 00166B105 identifies ALXO - ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 00166B105:
Top shareholders of ALXO - ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| LSV Associates, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
4,526,963
|
$61,575,751 | — | 13 Dec 2021 | |
| venBio Partners LLC |
13F
|
Company |
7.3%
|
9,699,925
|
$43,843,661 | — | 31 Mar 2023 | |
| FMR LLC |
13F
|
Company |
4.6%
|
6,129,441
|
$27,705,073 | — | 31 Mar 2023 | |
| Vivo Capital, LLC |
13F
|
Company |
3.2%
|
4,220,048
|
$19,074,617 | — | 31 Mar 2023 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
2.2%
|
2,871,000
|
$12,976,920 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.3%
|
1,668,624
|
$7,542,180 | — | 31 Mar 2023 | |
| Logos Global Management LP |
13F
|
Company |
1.1%
|
1,500,000
|
$6,780,000 | — | 31 Mar 2023 | |
| BRAIDWELL LP |
13F
|
Company |
0.94%
|
1,249,900
|
$5,649,548 | — | 31 Mar 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.78%
|
1,035,539
|
$4,680,637 | — | 31 Mar 2023 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.5%
|
664,829
|
$3,005,027 | — | 31 Mar 2023 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.46%
|
612,079
|
$2,767,000 | — | 31 Mar 2023 | |
| Redmile Group, LLC |
13F
|
Company |
0.44%
|
586,977
|
$2,653,136 | — | 31 Mar 2023 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.39%
|
510,666
|
$2,308,210 | — | 31 Mar 2023 | |
| Artal Group S.A. |
13F
|
Company |
0.38%
|
500,000
|
$2,260,000 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.32%
|
421,044
|
$1,903,118 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.3%
|
393,944
|
$1,780,627 | — | 31 Mar 2023 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.26%
|
346,789
|
$1,567,487 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.24%
|
314,186
|
$1,420,123 | — | 31 Mar 2023 | |
| Samsara BioCapital, LLC |
13F
|
Company |
0.2%
|
262,786
|
$1,187,793 | — | 31 Mar 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.18%
|
242,882
|
$1,097,826 | — | 31 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.15%
|
198,557
|
$897,477 | — | 31 Mar 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.14%
|
180,647
|
$816,525 | — | 31 Mar 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.11%
|
150,472
|
$680,133 | — | 31 Mar 2023 | |
| LOS ANGELES CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.11%
|
143,507
|
$648,652 | — | 31 Mar 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.1%
|
126,819
|
$573,000 | — | 31 Mar 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.09%
|
120,000
|
$542,400 | — | 31 Mar 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.08%
|
108,351
|
$489,747 | — | 31 Mar 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.07%
|
98,064
|
$443,000 | — | 31 Mar 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.07%
|
92,412
|
$417,748 | — | 31 Mar 2023 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.07%
|
90,624
|
$409,620 | — | 31 Mar 2023 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.06%
|
82,545
|
$373,000 | — | 31 Mar 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.05%
|
69,025
|
$311,993 | — | 31 Mar 2023 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.05%
|
66,211
|
$299,274 | — | 31 Mar 2023 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.05%
|
63,231
|
$285,804 | — | 31 Mar 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.04%
|
52,906
|
$239,000 | — | 31 Mar 2023 | |
| MARTINGALE ASSET MANAGEMENT L P |
13F
|
Company |
0.03%
|
44,609
|
$201,633 | — | 31 Mar 2023 | |
| Trexquant Investment LP |
13F
|
Company |
0.03%
|
43,269
|
$195,576 | — | 31 Mar 2023 | |
| Nan Fung Group Holdings Ltd |
13F
|
Company |
0.03%
|
41,950
|
$189,614 | — | 31 Mar 2023 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.03%
|
41,075
|
$185,659 | — | 31 Mar 2023 | |
| Swiss National Bank |
13F
|
Company |
0.03%
|
39,500
|
$178,540 | — | 31 Mar 2023 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.03%
|
38,907
|
$176,000 | — | 31 Mar 2023 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.03%
|
33,869
|
$153,088 | — | 31 Mar 2023 | |
| Financial Advisory Group |
13F
|
Company |
0.02%
|
31,417
|
$142,005 | — | 31 Mar 2023 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.02%
|
30,000
|
$135,600 | — | 31 Mar 2023 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.02%
|
26,850
|
$121,362 | — | 31 Mar 2023 | |
| XTX Topco Ltd |
13F
|
Company |
0.02%
|
25,817
|
$116,693 | — | 31 Mar 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
25,405
|
$114,830 | — | 31 Mar 2023 | |
| Deutsche Girozentrale DekaBank |
13F
|
Individual |
0.02%
|
24,300
|
$111,000 | — | 31 Mar 2023 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.02%
|
24,043
|
$108,674 | — | 31 Mar 2023 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.02%
|
22,780
|
$102,966 | — | 31 Mar 2023 |
Institutional Holders of ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO) as of Q2 2023
As of 30 Jun 2023,
ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO) was held by
74 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,283,564 shares.
The largest 10 holders included
venBio Partners LLC, FMR LLC, Vivo Capital, LLC, ORBIMED ADVISORS LLC, BlackRock Inc., Redmile Group, LLC, BRAIDWELL LP, VANGUARD GROUP INC, Logos Global Management LP, and Cormorant Asset Management, LP.
This page lists
74
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
85
Q2 2023 holders
74
Holder diff
-11
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.